Hydroxychloroquine Associated With Lower COVID-19 Mortality: Study

The French study included 30,202 patients.

A pharmacy technician pours out hydroxychloroquine pills at Rock Canyon Pharmacy in Provo, Utah, in a file photograph. George Frey/AFP via Getty Images

COVID patients who were treated with hydroxychloroquine were less likely to die than those who weren’t, according to a new study.

Just 0.8 percent of patients at a facility in France who received hydroxychloroquine (HCQ) and an antibiotic died, compared with 4.8 percent of patients who didn’t receive the drug combination, French researchers reported on Nov. 1.